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Open acAbstract Background and aims: Atherosclerosis is known to be an inflammatory disease and
there is increasing evidence that chylomicron remnants (CMR), the lipoproteins which carry
dietary fats in the blood, cause macrophage foam cell formation and inflammation. In early
atherosclerosis the frequency of activated monocytes in the peripheral circulation is
increased, and clearance of CMR from blood may be delayed, however, whether CMR
contribute directly to monocyte activation and subsequent egress into the arterial wall has
not been established. Here, the contribution of CMR to activation of monocyte pro-
inflammatory pathways was assessed using an in vitro model.
Methods and results: Primary human monocytes and CMR-like particles (CRLP) were used to
measure several endpoints of monocyte activation. Treatment with CRLP caused rapid and pro-
longed generation of reactive oxygen species by monocytes. The pro-inflammatory chemokines
MCP-1 and IL-8 were secreted in nanogram quantities by the cells in the absence of CRLP. IL-8
secretion was transiently increased after CRLP treatment, and CRLP maintained secretion in
the presence of pharmacological inhibitors of IL-8 production. In contrast, exposure to CRLP
significantly reduced MCP-1 secretion. Chemotaxis towards MCP-1 was increased in monocytes
pre-exposed to CRLP and was reversed by addition of exogenous MCP-1.
Conclusion: Our findings indicate that CRLP activate human monocytes and augment their
migration in vitro by reducing cellular MCP-1 expression. Our data support the current hypoth-
esis that CMR contribute to the inflammatory milieu of the arterial wall in early atheroscle-
rosis, and suggest that this may reflect direct interaction with circulating blood monocytes.
ª 2010 Elsevier B.V. Open access under CC BY license.7468 1216; fax: þ44 20 7468 5204.
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Monocyte activation, triggering their adhesion to the
endothelium and subsequent migration into the arterial
intima, is an early event in atherogenesis [1e4]. Trans-
formation into lipid-engorged macrophage foam cells
follows, and leads to the appearance of fatty streaks, the
first visible lesions in the vessel wall. Uptake of oxLDL by
monocyte/macrophages is known to play a significant role in
atherogenesis by stimulation of the secretion of pro-
inflammatory cytokines, chemokines and other factors [5],
but there is now considerable evidence to indicate that
chylomicron remnants (CMR), the lipoproteins which trans-
port fat of dietary origin from the gut to the liver, are also
strongly atherogenic [6].
Lipids from food are absorbed in the gut and secreted
into lymph in large, triacylglycerol (TG)-rich lipoproteins
called chylomicrons which then pass into the blood via the
thoracic duct. Here they undergo rapid lipolysis, a process
that removes some of their TG and forms the smaller CMR
which deliver the remaining TG, cholesterol and other
lipids to the liver [7]. Chylomicron remnants are taken up
and retained in the artery wall [8,9], and remnant-like
particles have been isolated from the neointima of human
atherosclerotic plaque and in animal models of athero-
sclerosis [10,11]. Delayed clearance of CMR correlates with
the development of atherosclerotic lesions, and is associ-
ated with consumption of Western diets, obesity and type 2
diabetes [12,13].
Data from this laboratory and others has demonstrated
that CMR are taken up by human macrophages derived from
the human monocyte cell line THP-1 or from macrophages
derived from freshly isolated monocytes [14,15] inducing
foam cell formation [16], expression of genes involved in
lipid metabolism [17] and modulation of pro-inflammatory
cytokine expression [18,19]. Furthermore, CMR inhibit
endothelium-dependent relaxation of isolated arteries
[8,20,21], and trigger pro-inflammatory signal transduction
in human endothelial cells (EC; [22]).
Monocytes are the precursors of macrophage foam cells
and thus have a crucial role in atherogenesis. Under
inflammatory conditions, activation of both monocytes and
EC triggers expression of adhesion molecules, cytokines and
vasoactive mediators and promotes monocyte adhesion to
the endothelium and subsequent migration into the arterial
wall [1,2,4]. The potential role of dietary fats in pro-
inflammatory activation of circulating monocytes has not
been explored experimentally, but TG-mediated expression
of CD11b/Mac-1 has been reported after oral fat loading in
normal healthy human volunteers [23,24].
Oxidative burst or reactive oxygen species (ROS) forma-
tion is a hallmark of monocyte activation and uptake of
oxLDL by monocytes or monocyte-derived macrophages is
known to be accompanied by ROS production [25]. We have
shown previously that CMR induce ROS in THP-1 monocytes
[26]. However, whether uptake of CMR by primary mono-
cytes can induce ROS has not been investigated.
The aim of this study was to determine whether pro-
inflammatory pathways are activated after monocyte
interaction with CMR in vitro using primary human mono-
cytes and model chylomicron remnant-like particles(CRLP). The effects of CRLP on; lipid accumulation; ROS
generation; the secretion of the pro-inflammatory chemo-
kines monocyte chemoattractant protein-1 (MCP-1) (also
known as CCL2 in humans) and interleukin-8 (IL-8); and
chemotaxis to MCP-1 by the cells were investigated. In
addition, pharmacological inhibitors were used to gain
information about the signalling pathways involved in the
effects of CRLP on ROS generation and chemokine
secretion.
Methods
All chemicals and tissue culture reagents were from Sigma
(Poole, Dorset, UK) unless otherwise stated. Tissue culture
plastics were from Falcon Discovery Labware range (Fisher
Scientific, UK), apart from Transwells which were from
Greiner BioOne (Gloucestershire, UK). Pyrollidine dithio-
carbamate (PDTC), U0126, apocynin, diphenyleneiodonium
chloride (DPI), phenylarsine oxide (PAO) allopurinol and N-
acetyl cysteine were all purchased from Sigma. U0124 was
from Tocris Bioscience (Bristol, UK).
Preparation of CRLP
CRLP were prepared by sonication of a lipid mixture con-
taining 70% trilinolein, 2% cholesterol, 3% cholesteryl ester
and 25% phospholipids in 0.9% NaCl (w/v) in Tricine Buffer
(20 mM, pH7.4), followed by ultracentrifugation on a step-
wise density gradient as described previously [27]. For apoE
binding, lipid particles collected from the top layer of the
final centrifugation step were incubated with the dialysed
(18 h, 4 C) d 1.063e1.21 g/ml fraction of human plasma
(National Blood Transfusion Service, North London Centre,
UK) as before [14]. CRLP containing apoE were then iso-
lated by ultracentrifugation at d 1.006 g/ml (120,000  g,
12 h, 4 C), collected from the top layer, purified by
a second centrifugation at the same density (202,000  g,
4 h, 4 C) and stored at 4 C under argon until required
[14,17]. All preparations were used within one week. To
control for the possible presence of factors originating from
plasma which may be present in the top layer after
centrifugation, incubations with control preparations
obtained by a similar procedure to that described for CRLP,
but in the absence of the lipid particles, were included in
all experiments. In all cases the data obtained with
monocytes incubated with control preparations were not
significantly different from those derived from cells incu-
bated in medium alone.
Isolation of human peripheral blood monocytes
Blood was taken by venepuncture from healthy volunteers
into 15% EDTA tubes, with approval from the East London
Research Ethics Committee. Monocytes were isolated by
negative selection using RosetteSep according to the man-
ufacturer’s instructions (StemCell Technologies, London,
UK). Cells were resuspended in RPMI containing 2 mM L-
glutamine, 10,000 units/ml Penicillin, 10 mg/ml strepto-
mycin and 10%(v/v) fetal bovine serum (PAA, Somerset,
UK). Monocyte preparations were routinely stained with
Figure 1 Lipid accumulation in CRLP-treated human mono-
cytes. Primary human monocytes were incubated with control
preparations (see Methods) or CRLP (final concentration 30 mg/
ml cholesterol) for 24 h. (A) Monocytes were adhered to
microscope slides by cytospin and stained with Oil Red O.
(B) Digital image analysis was carried out to determine lipid
uptake. Data are given as mean  sem of five experiments
using monocytes from five individual donors. ***p < 0.001 CRLP-
treated vs untreated or control treated monocytes.
Monocyte activation by chylomicron remnants 873anti-CD14 antibody (Becton Dickinson, Oxford, UK) fol-
lowed by flow cytometric analysis to verify purity.
Oil Red O staining
1  106 monocytes were incubated with CRLP (30 mg
cholesterol/ml) (or a similar volume of control prepara-
tion), and incubated at 37 C for 24 h. Cells were adhered
to microscope slides by cytospin (Shandon, ThermoFisher
Basingstoke, UK), and stained with Oil Red O as described
previously [14]. Images were captured using a microscope
mounted Canon digital camera and the extent of staining
analysed Image J analysis software (NIH).
Measurement of reactive oxygen species (ROS)
Monocytes were loaded with dihydrorhodamine-1,2,3 (final
concentration 100 mM) for 10 min at room temperature and
seeded onto white opaque 96 well tissue culture plates
(2.5  104 labelled monocytes/well). Pharmacological
inhibitors were added for 10 min at 37 C prior to addition
of CRLP (7.5e30 mg/ml cholesterol) or a similar volume of
control preparation. Plates were incubated at 37 C for up
to 24 h in 5% CO2 and fluorescence was measured, using
a Wallac1410 fluorescent microtitre plate reader (Perkin
Elmer, Beaconsfield, UK).
Measurement of chemokine secretion
Monocytes were seeded at 5  105 cells/well in 24 well
tissue culture plates and CRLP (30 mg/ml cholesterol) or
a similar volume of control preparation was added. Cells
were exposed to pharmacological inhibitors for 10 min at
37 C before addition of CRLP. After incubation at 37 C for
6 or 24 h, cells were pelleted and the supernatants
collected, snap frozen and stored at 80 C until analysis
using ELISA Duoset assay kits according to the manu-
facturer’s instructions (R&D Systems, Oxford, UK).
Chemotaxis assay
Monocytes were seeded at in 24 well tissue culture plates
(5  105 cells/well) and exposed to CRLP (30 mg choles-
terol/ml) or a similar volume of control preparation for
24 h, then transferred to the upper chamber of Transwell
plates in conditioned medium. RPMI supplemented with 10%
FBS (600 ml) was placed in the lower Transwell chambers
and recombinant human MCP-1 (CCL2) (10 ng/ml; R&D
Systems) was added to lower and/or upper chambers. The
plates were incubated for 4 h and the number of cells that
had migrated into the lower chamber after this time were
counted by flow cytometry (Beckman Coulter, Oxford UK).
Statistical analysis
Two way ANOVA followed by Bonferroni’s multiple
comparison test was used to analyse ROS production and
the effects of pharmacological inhibitors on cytokine
production, and one way ANOVA followed by the Tukey
Kramer multiple comparison test was used for all other
data, except where indicated otherwise.Results
Induction of lipid accumulation in monocytes
Incubation of isolated monocytes with CRLP for 24 h
resulted in increased intracellular accumulation of lipid as
assessed by Oil Red O staining (Figure 1A). Quantification of
the staining density using digital image analysis showed
that there was a highly significant increase in the lipid
content of CRLP-treated monocytes when compared to
cells exposed to the control preparation (P < 0.001, paired
Student’s t test) (Figure 1B).
Generation of reactive oxygen species
On incubation of dihydrorhodamine-1,2,3-loaded mono-
cytes with CRLP (7.5e30 mg cholesterol/ml) there was
a rapid increase in ROS formation in comparison to that
observed in control cells; after 1 h exposure to CRLP at
a dose of 7.5 mg cholesterol/ml there was a 7.5 fold
increase which was maintained for at least 24 h and was not
dose dependent (Figure 2). PDTC, a well-characterised
antioxidant with reported ability to inhibit NF-kB activity,
reduced both basal and CRLP-induced ROS production
(Figure 3A). In contrast, inhibitors of NADPH oxidase
Figure 2 ROS generation by monocytes incubated with CRLP
for up to 48 h. Freshly isolated monocytes were pre-loaded
with dihydrorhodamine-1,2,3 before addition varying concen-
trations of CRLP (0e30 mg cholesterol/ml) or an equal volume
of control preparation, and fluorescence was detected using
a microtitre plate reader at times up to 24 h. Data are as the
mean  sem of four experiments using monocytes from four
individual donors *p < 0.05 CRLP (all concentrations) compared
to control treated cells.
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(allopurinol; Figure 3F) had no significant effect on ROS
production in CRLP-treated cells. Similarly, neither the MEK
inhibitor U0126 (Figure 3B) nor its inactive analogue U0124
(data not shown), affected ROS generation in the presence
of CRLP.
Modulation of chemokine secretion
Freshly isolated human monocytes were incubated with or
without CRLP for 6 or 24 h and the secretion of MCP-1 and IL-8
into the medium was measured (n Z 5). In the absence of
CRLP, the cells secreted high quantities of MCP-1 (CCL2)
(5.01  1.58 ng/ml) and IL-8 (CXCL8) (1.54  0.24 ng/ml)
after 24 h. Secretion of MCP-1 was decreased by CRLP
treatment and this effect was significant after 24 h (6 h,
2.78  0.84 ng/ml; 24 h, 0.65  0.01 ng/ml (P < 0.05))
(Figure 4A), whilst IL-8 secretion into the medium was
increased at 6 h (3.34 0.30 ng/ml, P< 0.001) and returned
to control levels by 24 h (2.77  0.11 ng/ml) (Figure 4B).
Constitutive secretion of both MCP-1 and IL-8 was
significantly reduced by treatment with U0126. Production
of MCP-1 and IL-8 was also inhibited by PDTC, whereas the
NADPH oxidase inhibitor, apocynin, had no effect
(Figure 4A, B). Incubation with CRLP did not influence the
reduced MCP-1 secretion observed following treatment
with U0126 or PDTC (Figure 4A) but restored IL-8 secretion
to constitutive levels in the presence of either inhibitor
(Figure 4B.).
Monocyte chemotaxis
We hypothesised that the CRLP-driven reduction in MCP-1
secretion may result in increased monocyte chemotaxis due
to the resulting increased MCP-1 concentration gradient in
the monocyte microenvironment. This was investigated in
vitro by testing the migration of cells towards MCP-1 using
Transwell chambers (Figure 5). After pre-exposure to
control preparations for 24 h, the number of monocytes
migrating to the lower chamber of the Transwells was not
significantly different in the presence or absence of MCP-1in the lower chamber (Figure 5). Pre-treatment with CRLP,
however, caused a significantly higher percentage of
monocytes to migrate towards recombinant MCP-1. Addi-
tion of recombinant MCP-1 to CRLP-treated monocytes
before commencement of the migration assay abolished
this effect (Figure 5).Discussion
Recent studies have suggested that the interaction of CMR
with monocytes may play a part in their atherogenic
effects [22,24,27]. Studies in human leukocytes isolated
from subjects after ingestion of a fat meal have shown that
they take up TG-rich lipoproteins obtained from the same
subjects 4 h postprandially, and that this results in
increased expression of activation markers including CD11b
[23,24]. This is likely to be significant for development of
atherosclerosis, particularly when the removal of CMR
from the blood is delayed as occurs in relatively common
conditions such as obesity and type 2 diabetes [28].
Chylomicron remnants have been shown to influence
cytokine and chemokine expression in monocyte-derived
THP-1 macrophages [18,19], however, the potential acti-
vation of pro-inflammatory, pro-atherogenic signalling in
primary human undifferentiated monocytes by CMR has not
been explored previously. In the present study we have
shown that CRLP cause lipid accumulation in primary
human monocytes and that this is associated with rapid
and prolonged ROS production, the modulation of secre-
tion of the chemokines IL-8 and MCP-1 and increased
chemotaxis towards MCP-1.
Since CMR uncontaminated with other TG-rich lipopro-
teins such as chylomicrons and very lowdensity lipoprotein
(VLDL) cannot be obtained easily from human blood, we
used model CRLPs containing human apoE for our experi-
ments. In extensive previous work, we and others have
shown that these particles mimic the effects of physiolog-
ical CMR both in vivo and in vitro [7,14,29].
Previous work by Alipour et al. [23] suggested that
leukocytes isolated postprandially from volunteers fed
a high fat diet take up lipid from TG-rich lipoprotein such as
CMR, since they became enriched in meal-derived fatty
acids. Our experiments, however, demonstrate directly
that exposure of human monocytes to CRLP causes lipid to
accumulate inside the cells (Figure 1), and thus provide the
first direct evidence of CMR uptake by monocytes.
Oxidative or respiratory bursts in monocytes generate
reactive oxygen species (ROS) primarily as a defence
mechanism against infection, but are also generated by
these cells during other inflammatory reactions. In the
current study, CRLP were found to cause a large (x 7.5e8),
rapid and prolonged increase in the generation of ROS in
monocytes (Figure 2). Previous studies have shown that
human monocytes generate ROS in response to oxidised LDL
[25], and CMR from rats have been found to upregulate ROS
production by the THP-1 human monocyte cell line [30].
However, this is the first report to demonstrate that CRLP
promote ROS production in primary human monocytes.
The ERK1/2 and NF-kB pathways have been implicated in
inflammation-driven ROS generation and cardiovascular
disease [4,31]. U0126 is a well defined pharmacological
Figure 3 Inhibition of CMR-mediated ROSgeneration. Freshly isolatedmonocyteswere loadedwithDHR1,2,3 thenpre-treatedwith
20 mM PDTC (A), 1 mM MEK inhibitor U0126 (B) 100 mM Apocynin (C), 100 mM NADPH oxidase inhibitor PAO (D), 10 mM NADPH oxidase
inhibitor DPI (E), 100 mM xanthine oxidase inhibitor allopurinol (F), before addition of CRLP (30 mg cholesterol/ml) or control prepa-
rations (see Methods), and fluorescence was detected using a microtitre plate reader at increasing times. Plots are all mean sem of
four experiments using monocytes from four individual donors *p < 0.05 CRLP compared to CRLP þ inhibitor treated cells.
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and PDTC is often used to block NF-kB activation, since it
stabilizes the cytosolic NF-kB inhibitor, IkB-a, via inhibition
of IkB-a ubiquitination [32,33] and alters the oxidation
state of NF-kB subunits [34]. We used these inhibitors,
therefore, to determine the role of the ERK1/2 and NF-kB
pathways in CRLP-induced ROS production in human
monocytes. U0126 was shown to prevent the accumulation
of ROS in untreated cells, but did not affect CRLP-mediated
ROS generation. In contrast, PDTC inhibited ROS production
in both control and CRLP-treated cells (Figure 3A). These
results are consistent with the previous finding that ingestionof a meal high in butter or walnut oil fat activates NF-kB in
peripheral blood mononuclear cells from healthy volunteers
[35] and suggest that the induction of ROS generation by
CMR in human monocytes is mediated by NF-kB, but that
the ERK1/2 pathway is not involved. Interestingly, in
a recent study from our group we showed that CRLP
downregulate NF-kB activity in macrophages derived from
THP-1 monocytes [18] suggesting that there are differences
in the effects of CRLP on monocytes as compared to
macrophages.
NADPH oxidase acts as a catalyst of the transfer of
electrons from NADPH to O2, which results in the formation
Figure 4 Effect of the inhibitors U0126, PDTC, and apocynin
on chemokine secretion by primary human monocytes. Freshly
isolated monocytes were pre-incubated without (control) or
with U0126 (1 mM) PDTC (100 mM) or apocynin (100 mM) for
10 min before addition of CRLP (30 mg/ml cholesterol).
Supernatant was collected after 20 h and levels of MCP-1 (A) or
IL-8 (B) were measured by ELISA. Data are given as mean  sem
of five experiments using monocytes from five individual
donors *p < 0.05; **p < 0.01; ***p < 0.001 compared to control
treated cells.
Figure 5 Monocyte chemotaxis towards MCP-1 after pre-
exposure to CRLP for 24 h. Monocytes were pre-incubated
with CRLP (30 mg/ml cholesterol) or control preparations (see
Methods), for 24 h before being placed into transwells
(0.6  106 cells/well) without washing. The lower chamber was
flooded with media with or without 10 ng/ml MCP-1 and incu-
bation was continued for a further 4 h before counting cells
that had migrated to the lower chamber by flow cytometry.
Data are given as mean  sem of six experiments using
monocytes from six individual donors. *p < 0.05.
876 C. Bentley et al.of superoxide anion and other ROS involved in microbial
defence [36]. More recently, NADPH oxidase has been
shown to be a family of enzymes critically involved in the
tissue damage caused by oxidative stress in atherogenesis
[37]. TNF-induced ROS production has been reported to
occur through NF-kB-mediated transcriptional regulation of
the NADPH oxidase genes in MonoMac1, a human monocyte
cell line [38]. Thus, we sought to determine the role of
NADPH oxidases in CRLP-stimulated ROS production using
the NADPH oxidase inhibitors apocynin, DPI and PAO [39e
41]. However, none of the inhibitors affected the pro-
longed CRLP-mediated generation of ROS. Likewise, allo-
purinol, an inhibitor of xanthine oxidase, which has also
been implicated in ROS generation in atherosclerosis [42],
did not prevent the increase in ROS found in monocytes in
response to CRLP. We conclude, therefore, that CRLP do
not stimulate ROS production via modification of either
NADPH oxidase or xanthine oxidase activity.
It is well established that human peripheral blood
monocytes secrete MCP-1 and IL-8 and that synthesis of
these chemokines increases following exposure to pro-inflammatory stimuli. A surprising finding of the current
study, therefore, is that CRLP cause a marked decrease in
monocyte MCP-1 secretion in monocytes, particularly since
previous studies have shown that both CMR and ROS
production induce MCP-1 secretion from vascular smooth
muscle cells [43], and that agents that reduce ROS forma-
tion suppress NF-kB dependent MCP-1 secretion in mono-
cytes in vitro [44]. In contrast, IL-8 secretion by the
monocytes was transiently increased after 6 h incubation
with CRLP. However, since CRLP reversed the inhibition
caused by PDTC or U0126 (Figure 4B), we conclude that
their stimulatory effect is not mediated via the MEK/ERK
pathway.
Considering the potential effects of the decrease in
MCP-1 secretion caused by CMR on the migration of mono-
cytes, we hypothesised that reduced levels of monocyte-
derived MCP-1 in the microenvironment of the blood vessel
lumen may increase the MCP-1 chemotactic gradient across
the endothelium. In order to test this, we investigated how
CRLP pre-treatment affected monocyte chemotaxis across
a transwell filter towards MCP-1. As predicted, decreased
MCP-1 levels in the culture medium of monocytes after
treatment with CRLP enhanced the subsequent migration of
the cells towards a higher concentration of MCP-1, and
furthermore, this effect was reversed by addition of exog-
enous MCP-1 to the culture medium after the incubation
with CRLP (Figure 5). We propose, therefore that CMR have
an overall pro-migratory effect on circulating monocytes
via down-regulation of their constitutive MCP-1 secretion
(Figure 4A). Enhancement of IL-8 secretion by CMR may also
increase monocyte migration, since this chemokine has
recently been reported to activate monocytes during firm
adhesion to the endothelium [45].
Monocyte activation by chylomicron remnants 877In summary, this study demonstrates that CRLP cause
lipid accumulation in peripheral blood monocytes and
induce prolonged ROS production. Moreover, CRLP inhibit
MCP-1 secretion and enhance their migration towards MCP-
1. These findings indicate a pro-inflammatory, pro-migra-
tory effect of CMR on peripheral blood monocytes, and
support the current hypothesis that CMR contribute to the
inflammatory milieu seen in susceptible areas of the artery
wall in early atherosclerosis.Acknowledgements
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